Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Stavreus Evers Anneli) "

Sökning: WFRF:(Stavreus Evers Anneli)

  • Resultat 1-10 av 83
  • [1]234567...9Nästa
Sortera/gruppera träfflistan
  • Laanpere, Margit, et al. (författare)
  • Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability
  • 2010
  • Ingår i: Nutrition reviews. - 0029-6643 .- 1753-4887. ; 68:2, s. 99-113
  • Tidskriftsartikel (refereegranskat)abstract
    • This review summarizes current knowledge of the effect of folate-mediated one-carbon metabolism and related genetic variants on female fertility and pregnancy viability. Insufficient folate status disrupts DNA methylation and integrity and increases blood homocysteine levels. Elevated levels of follicular fluid homocysteine correlate with oocyte immaturity and poor early embryo quality, while methylenetetrahydrofolate reductase (MTHFR) gene variants are associated with lower ovarian reserves, diminished response to follicular stimulation, and reduced chance of live birth after in vitro fertilization. Embryos carrying multiple MTHFR variants appear to have a selective disadvantage; however, the heterozygousMTHFR 677CT genotype in the mother and fetus provides the greatest chance for a viable pregnancy and live birth, possibly due to a favorable balance in folate cofactor distribution between methyl donor and nucleotide synthesis. The results of previous studies clearly emphasize that imbalances in folate metabolism and related gene variants may impair female fecundity as well as compromise implantation and the chance of a live birth.
  • Hambiliki, F., et al. (författare)
  • Glycoprotein 130 promotes human blastocyst development in vitro
  • 2013
  • Ingår i: Fertility and Sterility. - 0015-0282 .- 1556-5653. ; 99:6, s. 1592-U444
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To investigate the efficacy of leukemia inhibitory factor (LIF) and/or glycoprotein 130 Design: Laboratory study. Setting: University hospital-based IVF clinic. Patient(s): A total of 164 frozen embryos that survived thawing were cultured in media supplemented Intervention(s): Morphological development was evaluated by light microscopy. Protein expression Main Outcome Measure(s): Embryo development and protein content. Result(s): Addition of gp130 to culture media improved blastocyst formation (73% vs. 43%). Addition of Conclusion(s): Glycoprotein 130, but not LIF, seems to be beneficial for preimplantation embryo
  • Kunovac Kallak, T., et al. (författare)
  • Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients
  • 2012
  • Ingår i: Climacteric. - London, United Kingdom : Informa Healthcare. - 1369-7137 .- 1473-0804. ; 15:5, s. 473-480
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Vaginal estradiol is considered contraindicated in aromatase inhibitor (AI)-treated patients because of the risk of elevated estrogen levels. This leaves limited treatment options for patients experiencing gynecological symptoms. However, in clinical practice, no precise estimation has been performed of circulating estrogens and aromatase index in postmenopausal breast cancer patients on long-lasting AI or tamoxifen treatment.Methods: Steroid hormones were measured using liquid chromatography tandem mass spectrometry (LC-MS/MS) and extraction radioimmunoassay (RIA). Postmenopausal AI-treated patients (n =33) were compared with tamoxifen-treated patients (n =34) and controls without vaginal treatment (n =56), with vaginal estradiol (n =25), or with estriol (n =11) treatment.Results: By use of LC-MS/MS, median (range) estradiol plasma concentrations were 16.7 (2.4-162.6), 31.0 (13.4-77.1), 27.2 (7.8-115.8) and 33.3 (20.3-340.1) pmol/l in AI-treated breast cancer patients, tamoxifen-treated breast cancer patients, postmenopausal controls and postmenopausal controls on vaginal estradiol, respectively. The AI-treated group and subgroups had significantly lower estradiol and estrone concentrations than all other groups (p <0.05). There was extensive interindividual variation in estradiol concentration within the AI-treated group, measured using both LC-MS/MS (2.3-182.0 pmol/l) and extraction RIA (2.4-162.6 pmol/l). The AI-treated group had lower aromatase index compared to all other groups (p <0.05-0.001).Conclusion: Circulating estrogen levels may have been underestimated in previous longitudinal studies of AI-treated breast cancer patients. Additional studies are required to further evaluate the role of circulating estrogens in breast cancer patients suffering from gynecological symptoms.
  • Murto, T., et al. (författare)
  • Folic acid supplementation and IVF pregnancy outcome in women with unexplained infertility
  • 2014
  • Ingår i: ; 28:6, s. 766-772
  • Tidskriftsartikel (refereegranskat)abstract
    • Folic acid supplements are commonly used by infertile women and lead to a positive folate status. However, the effect of folic acid supplements on pregnancy outcome in women with unexplained infertility has not been well investigated. This study evaluated folic acid supplement use and folate status in women with unexplained infertility in relation to pregnancy outcome. In addition, use of folic acid supplements and folate status were compared between women with unexplained infertility and fertile, nonpregnant control women. Women with unexplained infertility used significantly more folic acid supplements and had higher median total folic acid intake from supplements compared with fertile control women (both P < 0.001). Women with unexplained infertility also had significantly higher median plasma folate and lower median plasma homocysteine concentrations than fertile women (both P < 0.001), but folic acid supplementation or folate status were not related to pregnancy outcome in women with unexplained infertility. In conclusion, folic acid supplementation or good folate status did not have a positive effect on pregnancy outcome following infertility treatment in women with unexplained infertility.
  • Baumgart, Juliane, 1978-, et al. (författare)
  • Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer
  • 2013
  • Ingår i: ; 20:2, s. 162-168
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: The goal of this study was to investigate sexual function in postmenopausal breast cancer patients treated with aromatase inhibitors.Methods: A population-based, cross-sectional study was conducted among postmenopausal breast cancer patients on adjuvant endocrine treatment and age-matched controls with and without estrogen treatment. Sexual function was assessed with a standardized questionnaire.Results: In all, 42.4% of aromatase inhibitor-treated breast cancer patients were dissatisfied with their sex life in general, and 50.0% reported low sexual interest; this was significantly more common than in tamoxifen-treated patients and controls (P < 0.05). Aromatase inhibitorYtreated patients reported insufficient lubrication in 73.9% and dyspareunia in 56.5% of cases, which were significantly more common than in controls, irrespective of hormonal use (P < 0.05). Tamoxifen-treated patients reported significantly more dyspareunia (31.3%; P < 0.05) but resembled controls in all other concerns.Conclusions: Our findings suggest that sexual dysfunction in aromatase inhibitorYtreated women is a greatly underestimated problem.
  • Aghajanova, Lusine, et al. (författare)
  • Diminished endometrial expression of ghrelin and ghrelin receptor contributes to infertility
  • 2010
  • Ingår i: Reproductive sciences (Thousand Oaks, Calif.). - 1933-7205. ; 17:9, s. 823-832
  • Tidskriftsartikel (refereegranskat)abstract
    • The objectives were to investigate the presence, distribution and sex steroid hormone regulation of ghrelin and its receptor, growth hormone secretagogue receptor (GHSR), in human endometrium in relation to endometrial receptivity and fertility. Endometrial biopsies were obtained from women with unexplained infertility and healthy fertile volunteers. Ishikawa cells were used to mimic the action of ghrelin in endometrium. Immunostaining of GHSR was strong in luminal epithelium and stroma during mid-secretory phase. Ghrelin and GHSR expression is less intense in mid-secretory endometrium of infertile women compared to fertile controls. Treatment with estrogen and/or progesterone or their antagonists did not significantly change the relative expression of GHSR in Ishikawa and stromal cells. Ghrelin was present in and secreted from human blastocysts, which suggest that the communication between human blastocyst and endometrium might involve ghrelin. Low levels of GHSR in endometrium from women with unexplained infertility may in part explain the infertility.
  • Aghajanova, Lusine, et al. (författare)
  • Disturbances in the LIF pathway in the endometrium among women with unexplained infertility
  • 2009
  • Ingår i: Fertility and Sterility. - 0015-0282 .- 1556-5653. ; 91:6, s. 2602-2610
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: To study the expression of leukemia inhibitory factor (LIF), its receptors LIFR and gp130, and its inhibitor SOCS1 in endometria from fertile women and infertile women with unexplained infertility. Signaling through the LIF pathway is involved in maintenance of a receptive state of human endometrium. Impaired endometrial receptivity may be a cause of female infertility. DESIGN: Prospective clinical study. SETTING: Hospital-based IVF unit and university-affiliated reproductive research laboratories. PATIENT(S): Twenty-six healthy fertile women and 14 women with unexplained infertility. INTERVENTION(S): Endometrial biopsy. MAIN OUTCOME MEASURE(S): Pinopode formation, expression of LIF, LIFR, gp130, and SOCS1 protein and mRNA in endometrial biopsies. RESULT(S): The expression of LIFR in the endometrium was negatively correlated to the expression of SOCS1 and positively correlated to the formation of pinopodes. In control fertile women, simultaneous intense apical staining of LIFR and gp130 together with faint SOCS1 staining was observed in epithelial cells, whereas the opposite was seen in most women with unexplained infertility. CONCLUSION(S): Unexplained infertility in some women might be explained by disturbances in the LIF pathway in midsecretory-phase endometrium.
  • Aghajanova, Lusine, et al. (författare)
  • HB-EGF but not amphiregulin or their receptors HER1 and HER4 is altered in endometrium of women with unexplained infertility
  • 2008
  • Ingår i: Reproductive Sciences. - 1933-7191. ; 15:5, s. 484-492
  • Tidskriftsartikel (refereegranskat)abstract
    • Heparin-binding, epidermal growth factor-like growth factor (HB-EGF) and its receptors (HER I and HER4) play a role in the human implantation process. Amphiregulin is a member of the EGF family but with unknown function in human fertility. It has been suggested that some women with unexplained infertility have defective endometrial development. The aim of this study is to determine the presence of amphiregulin and the receptors HER1 and HER4 in normal human endometrium throughout the menstrual cycle. In addition) the present study aims to compare endometrium from women with unexplained infertility with endometrium from women with male factor infertility and healthy fertile controls. Immunohistochemistry and real-time polymerase chain reaction were used to determine the expression of HB-EGF, HER 1, HER4, and amphiregulin. The stromal staining of HER I and the epithelial staining of HER4 were most intense in the mid- and late-secretory-phase endometrium. Amphiregulin did not vary during the menstrual cycle. In the mid-secretory phase, the protein expression of HB-EGF was lower in endometrium from women with unexplained infertility versus normal endometrium and endometrium from women with malefactor infertility. HB-EGF and HER4 mRNA expression in mid-secretory endometrium of women with unexplained and malefactor infertility were increased compared with normal controls. Impaired endometrial expression of certain members of the EGF family may contribute to infertility in some women with unexplained infertility.
  • Aghajanova, Lusine, et al. (författare)
  • Receptors for thyroid-stimulating hormone and thyroid hormones in human ovarian tissue
  • 2009
  • Ingår i: Reproductive Biomedicine Online. - 1472-6483 .- 1472-6491. ; 18:3, s. 337-347
  • Tidskriftsartikel (refereegranskat)abstract
    • Dysfunction in thyroid regulation can cause menstrual and ovulatory disturbances, the mechanism of which is not clear. The distribution and activity of the thyroid-stimulating hormone (TSHR), and the thyroid hormone receptors (TR) alpha1, alpha2 and beta1 in human ovarian tissue and in granulosa cells was studied using immunohistochemistry, reverse-transcriptase polymerase chain reaction (RT-PCR), quantitative PCR and immunoassays. Strong immunostaining of TSHR, TRalpha1 and TRbeta1 was observed in ovarian surface epithelium and in oocytes of primordial, primary and secondary follicles, with minimal staining in granulosa cells of secondary follicles. Granulosa cells of antral follicles expressed TSHR, TRalpha1 and TRbeta1 proteins. Messenger RNA for all receptors was present in ovarian tissue. Mature human granulosa cells expressed transcripts for 5' deiodinases types 2 and 3, but not type 1, indicating the possibility of conversion of peripheral thyroid hormone thyroxin (T(4)). Granulosa cells stimulated with TSH showed a significant increase in cAMP concentrations after 2 h of culture (P = 0.047), indicating activation through TSHR. Stimulation with T(4) resulted in increased extracellular signal-regulated kinase 1 and 2 activation after 10, 30, 60 min and 24 h. These data demonstrate that TSH and thyroid hormone receptors may participate in the regulation of ovarian function.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 83
  • [1]234567...9Nästa
Typ av publikation
tidskriftsartikel (71)
doktorsavhandling (7)
forskningsöversikt (3)
annan publikation (2)
Typ av innehåll
refereegranskat (67)
övrigt vetenskapligt (16)
Stavreus-Evers, Anne ... (58)
Stavreus-Evers, A (41)
Altmäe, Signe (19)
Stavreus-Evers, Anne ... (17)
Altmae, S (15)
Salumets, Andres (15)
visa fler...
Salumets, A (15)
Landgren, Britt-Mari ... (13)
Landgren, BM (12)
Wånggren, Kjell (10)
Wanggren, K (10)
Hovatta, O (9)
Nilsson, Torbjörn K (9)
Hovatta, Outi (8)
Sundström Poromaa, I ... (8)
Aghajanova, Lusine (7)
Aghajanova, L (6)
Skjoldebrand-Sparre, ... (6)
Altmae, Signe (6)
Yngve, A (6)
Nilsson, Kerstin, 19 ... (6)
Kallak, Theodora Kun ... (6)
Olovsson, Matts (6)
Skoog Svanberg, Agne ... (6)
Baumgart, Juliane, 1 ... (6)
Bergquist, J. (5)
Larsson, Anders (5)
Bjuresten, Kerstin (5)
Ronquist, Gunnar (5)
Akerud, H (5)
Yngve, Agneta, 1953- (5)
Sundstrom-Poromaa, I (5)
Åkerud, Helena (5)
Bergquist, Jonas (4)
Nilsson, TK (4)
Bjuresten, K (4)
Skjöldebrand-Sparre, ... (4)
Bremme, K (4)
Skjoldebrand-Sparre, ... (4)
Kallak, TK (4)
Kallak, Theodora Kun ... (4)
Bremme, Katarina (4)
Helmestam, Malin (4)
Sundström Poromaa, I ... (4)
Skoog Svanberg, Agne ... (4)
Kushnir, M. M. (4)
Åkerud, Helena, 1972 ... (4)
Stavreus-Evers, Anne ... (4)
Hosseini, Frida (4)
Hosseini, F (4)
visa färre...
Uppsala universitet (75)
Karolinska Institutet (32)
Örebro universitet (12)
Umeå universitet (6)
Göteborgs universitet (1)
Lunds universitet (1)
visa fler...
Linköpings universitet (1)
Chalmers tekniska högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Engelska (83)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (46)
Naturvetenskap (1)
Samhällsvetenskap (1)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy